This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08170/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08170/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB08170/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08170/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08170/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08170
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08170 n12:DB08170
dcterms:title
(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE
adms:identifier
n8:13085320 n9:DB08170 n11:99444641 n13:MDW n14:15942651
n3:IUPAC-Name
n4:271B6523-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6529-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6528-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6525-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6526-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6527-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6521-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6522-363D-11E5-9242-09173F13E4C5 n4:271B651F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6520-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B652F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6530-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B652A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B652B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B652D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B652C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B652E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6535-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6537-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6538-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6534-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6533-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6536-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6524-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6531-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6532-363D-11E5-9242-09173F13E4C5